Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

2.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

3.

[Interventional left atrial appendage occlusion : alternative to oral anticoagulation for stroke prevention in atrial fibrillation].

Meincke F, Kuck KH, Bergmann MW.

Herz. 2013 May;38(3):239-46. doi: 10.1007/s00059-013-3775-5. German.

PMID:
23575978
4.

Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.

Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J.

Clin Res Cardiol. 2016 Mar;105(3):225-9. doi: 10.1007/s00392-015-0910-8. Epub 2015 Aug 30.

PMID:
26318322
5.

Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.

Landmesser U, Holmes DR Jr.

Eur Heart J. 2012 Mar;33(6):698-704. doi: 10.1093/eurheartj/ehr393. Epub 2011 Oct 31. Review.

PMID:
22041550
6.

The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.

Ramlawi B, Abu Saleh WK, Edgerton J.

Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):100-3. doi: 10.14797/mdcj-11-2-100. Review.

7.

Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation.

Calvo N, Salterain N, Arguedas H, Macias A, Esteban A, García de Yébenes M, Gavira JJ, Barba J, García-Bolao I.

Europace. 2015 Oct;17(10):1533-40. doi: 10.1093/europace/euv070. Epub 2015 May 1.

PMID:
25935163
8.

Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.

Wiebe J, Bertog S, Franke J, Wettstein O, Lehn K, Hofmann I, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2014 Apr 1;83(5):796-802. doi: 10.1002/ccd.25329. Epub 2014 Jan 8.

PMID:
24327462
9.

Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.

Streb W, Szymała M, Kukulski T, Nowak J, Lekston A, Sokal A, Knapik P, Czapla J, Zbieralska E, Kalarus Z.

Kardiol Pol. 2013;71(1):8-16.

10.

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV.

J Vis Exp. 2013 Feb 26;(72):e3818. doi: 10.3791/3818.

11.

Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.

Pheerawong P, Songmuang SB, Lertsuwunseri V, Satitthummanid S, Srimahachota S.

J Med Assoc Thai. 2015 Oct;98(10):942-9.

PMID:
26638585
12.

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.

Price MJ, Reddy VY, Valderrábano M, Halperin JL, Gibson DN, Gordon N, Huber KC, Holmes DR Jr.

JACC Cardiovasc Interv. 2015 Dec 28;8(15):1925-32. doi: 10.1016/j.jcin.2015.08.035. Epub 2015 Nov 25.

13.

Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.

Gangireddy SR, Halperin JL, Fuster V, Reddy VY.

Eur Heart J. 2012 Nov;33(21):2700-8. doi: 10.1093/eurheartj/ehs292. Epub 2012 Sep 24.

PMID:
23008509
14.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.

J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6. doi: 10.1016/j.jacc.2013.03.035. Epub 2013 Apr 10.

15.

Role of Endovascular Closure of the Left Atrial Appendage in Stroke Prevention for Atrial Fibrillation.

Kiani J, Holmes DR Jr.

Curr Atheroscler Rep. 2015 Nov;17(11):65. doi: 10.1007/s11883-015-0542-5. Review.

PMID:
26408017
16.

Does left atrial appendage closure with a cardiac plug system reduce the stroke risk in nonvalvular atrial fibrillation patients? A single-center case series.

Danna P, Proietti R, Sagone A, Arensi A, Viecca M, Rago A, Russo V.

Pacing Clin Electrophysiol. 2013 Mar;36(3):347-53. doi: 10.1111/pace.12058. Epub 2012 Dec 17.

PMID:
23252940
17.

[Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].

Fontos G, Andréka P, Temesvári A, Wéber D, Szatmári A.

Orv Hetil. 2010 May 2;151(18):725-34. doi: 10.1556/OH.2010.28870. Review. Hungarian.

PMID:
20409999
18.

Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.

Heeger CH, Rillig A, Lin T, Mathew S, Deiss S, Lemes C, Botros M, Metzner A, Wissner E, Kuck KH, Ouyang F, Tilz RR.

Heart Rhythm. 2015 Jul;12(7):1524-31. doi: 10.1016/j.hrthm.2015.03.011. Epub 2015 Mar 10.

19.

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.

Grosset-Janin D, Barth E, Bertrand B, Detante O.

Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Review.

PMID:
25912470
20.

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.

Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.

Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.

PMID:
23973952

Supplemental Content

Support Center